LIRAGLUTIDE

Generic: LIRAGLUTIDE

Biocon Pharma Inc.Manufacturer
SUBCUTANEOUSRoute
LIRAGLUTIDEActive Substance
2026-03-11Original Approval

LIRAGLUTIDE is FDA application ANDA215245, sponsored by BIOCON PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class II2026-04-24
Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, M

Presence of particulate matter: a white thread-like structure in the cartridge

Top Reported Reactions

1
DYSPNOEA
304 reports
2
ANXIETY
223 reports
3
CONDITION AGGRAVATED
221 reports
4
NAUSEA
191 reports
5
ASTHMA
189 reports
6
THERAPEUTIC PRODUCT EFFECT INCOMPLETE
186 reports
7
WHEEZING
184 reports
8
HYPOTHYROIDISM
179 reports
9
PRODUCT DOSE OMISSION ISSUE
179 reports
10
VOMITING
175 reports